Note: Always inform your healthcare provider of all supplements and medications you are currently taking before starting a new weight loss program
For the PBM reforms in the recently-enacted appropriations law, CBO estimated a total federal deficit reduction of $2.12 billion over 10 years (2026-2035): A reduction of $444 million from delinking PBM compensation from the cost of medications for drugs under Part D and establishing PBM transparency and reporting requirements for Part D plans An increase of $188 billion from assuring pharmacy access and choice for Medicare beneficiaries A reduction of $1.865 billion from increasing oversight of PBMs that work with employer health plans, including $1.843 billion in additional revenues and savings of $22 million For the provision to increase oversight of PBMs that work with employer health plans, a prior CBO estimate of this provision assumed that because insurers had more information about the operations of their PBMs, it would lead to a reduction in prescription costs, and therefore a modest reduction in premiums charged in the group health insurance market, though savings would likely diminish over time
The payoff is simple: happier, healthier consumers who stay the courseand products that win in a rapidly expanding market
Studies show that patients on Tirzepatide (Zepbound) lost approximately 20% of their body weight over 72 weeks, whereas those on semaglutide (Wegovy) lost about 14% in the same timeframe
Elamipretide improves sperm cryopreservation outcomes and mitochondrial stability
Neurobiol Dis 2010;40:23844
